Based on Nrf2/NLRP3 inflammasome signaling pathway to explore the prevention and treatment mechanism of gouty arthritis with Modified Simiaowan.

[1]  Y. Li,et al.  Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Geng Li,et al.  Modified Baihu decoction therapeutically remodels gut microbiota to inhibit acute gouty arthritis , 2022, Frontiers in Physiology.

[3]  Y. Li,et al.  Smilax glabra Roxb.: A Review of Its Traditional Usages, Phytochemical Constituents, Pharmacological Properties, and Clinical Applications , 2022, Drug design, development and therapy.

[4]  Yang Yang,et al.  The role of obesity, type 2 diabetes, and metabolic factors in gout: A Mendelian randomization study , 2022, Frontiers in Endocrinology.

[5]  Jianhui Xie,et al.  Palmatine Protects Against MSU-Induced Gouty Arthritis via Regulating the NF-κB/NLRP3 and Nrf2 Pathways , 2022, Drug design, development and therapy.

[6]  Qian Wang,et al.  Distinct macrophage polarization in acute and chronic gout , 2022, Laboratory Investigation.

[7]  Jie Wang,et al.  Environmental factors and risk of gout. , 2022, Environmental research.

[8]  S. Lawler,et al.  Inflammasome activation: from molecular mechanisms to autoinflammation , 2022, Clinical & translational immunology.

[9]  Jing Han,et al.  Advances in Experimental and Clinical Research of the Gouty Arthritis Treatment with Traditional Chinese Medicine , 2021, Evidence-based complementary and alternative medicine : eCAM.

[10]  Yue Wang,et al.  Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation. , 2021, International immunopharmacology.

[11]  R. Zhou,et al.  NLRP3 inflammasome activation and cell death , 2021, Cellular & Molecular Immunology.

[12]  W. Liauw.  Western medicine and traditional Chinese medicine: encouraging the twain to meet , 2021, Internal medicine journal.

[13]  A. Doria,et al.  Autoinflammatory Features in Gouty Arthritis , 2021, Journal of clinical medicine.

[14]  Zhijun Xie,et al.  Qu-Zhuo-Tong-Bi Decoction Alleviates Gouty Arthritis by Regulating Butyrate-Producing Bacteria in Mice , 2021, Frontiers in Pharmacology.

[15]  Min Wu,et al.  Modified Simiaowan Prevents Articular Cartilage Injury in Experimental Gouty Arthritis by Negative Regulation of STAT3 Pathway. , 2021, Journal of ethnopharmacology.

[16]  Karl T. Clebak,et al.  Gout: Rapid Evidence Review. , 2020, American family physician.

[17]  Le Shi,et al.  Matrix Metalloproteinase-3 induces proteoglycan degradation in gouty arthritis model. , 2020, Gene.

[18]  U. Bandyopadhyay,et al.  Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective , 2020, Biochemical Pharmacology.

[19]  G. Keyßer.  [Gout arthritis: Pathogenesis, diagnostics and treatment]. , 2020, Deutsche medizinische Wochenschrift.

[20]  L. Jacobsson,et al.  Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors , 2020, Nature Reviews Rheumatology.

[21]  Zhenlian Wang,et al.  NLRP3 Inflammasome and Inflammatory Diseases , 2020, Oxidative medicine and cellular longevity.

[22]  Ke Ma,et al.  Chinese herbal medicine for gout: a review of the clinical evidence and pharmacological mechanisms , 2020, Chinese Medicine.

[23]  S. Nagamatsu,et al.  Gouty tophus without gout attacks treated using a reversed digital artery flap , 2020, Case reports in plastic surgery & hand surgery.

[24]  Yangang Wang,et al.  Progress in Treatment of Gout Using Chinese and Western Medicine , 2020, Chinese journal of integrative medicine.

[25]  W. Zou,et al.  Icariin Alleviates IL-1β-Induced Matrix Degradation By Activating The Nrf2/ARE Pathway In Human Chondrocytes , 2019, Drug design, development and therapy.

[26]  T. Cunha,et al.  Monosodium urate crystal interleukin-1β release is dependent on Toll-like receptor 4 and transient receptor potential V1 activation. , 2019, Rheumatology.

[27]  Yuan He,et al.  The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation , 2019, International journal of molecular sciences.

[28]  N. Dalbeth,et al.  Prevention and treatment of gout , 2018, Nature Reviews Rheumatology.

[29]  A. Van Schepdael,et al.  Oxidative stress in chronic kidney disease , 2018, Pediatric Nephrology.

[30]  L. Facci,et al.  Serum amyloid A primes microglia for ATP-dependent interleukin-1β release , 2018, Journal of Neuroinflammation.

[31]  Yuqiong Liang,et al.  Traditional Chinese Medicine Formula "Xiaofeng granules" suppressed gouty arthritis animal models and inhibited the proteoglycan degradation on chondrocytes induced by monosodium urate. , 2016, Journal of ethnopharmacology.

[32]  J. Saseen,et al.  Gouty Arthritis: A Review of Acute Management and Prevention , 2016, Pharmacotherapy.

[33]  Li Guochun,et al.  A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout. , 2015, Journal of ethnopharmacology.

[34]  Le Shi,et al.  Suppressive effect of modified Simiaowan on experimental gouty arthritis: an in vivo and in vitro study. , 2013, Journal of ethnopharmacology.

[35]  I. Mitroulis,et al.  Neutrophils, IL-1β, and gout: is there a link? , 2013, Seminars in Immunopathology.

[36]  Xiaofei Shang,et al.  Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine , 2011, Journal of Ethnopharmacology.

[37]  Guo-chun Li,et al.  Randomized and controlled clinical study of modified prescriptions of Simiao Pill (四妙丸) in the treatment of acute gouty arthritis , 2008 .

[38]  R. Terkeltaub,et al.  The inflammatory process of gout and its treatment , 2006, Arthritis research & therapy.

[39]  A. Cox.  Colchicine in acute gout , 2004, BMJ : British Medical Journal.

[40]  Hongping Ye,et al.  Treatment of 60 cases of gouty arthritis with modified Simiao Tang. , 2008, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.